{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:23:51Z","timestamp":1792167831318,"version":"4.4.0"},"reference-count":401,"publisher":"The Endocrine Society","issue":"3","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIDDK RO-1 38325-35"],"award-info":[{"award-number":["NIDDK RO-1 38325-35"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1210\/er.2018-00163","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T14:08:20Z","timestamp":1547474900000},"page":"789-824","source":"Crossref","is-referenced-by-count":526,"title":["Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders"],"prefix":"10.1210","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-4464","authenticated-orcid":false,"given":"Bernadette","family":"Biondi","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J","family":"Kahaly","sequence":"additional","affiliation":[{"name":"Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Paul","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology and Metabolism, University of Washington School of Medicine, Seattle, Washington"},{"name":"Department of Pharmacology, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"issue":"6","key":"2019050909192672800_B1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019050909192672800_B2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"2019050909192672800_B3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"9821","key":"2019050909192672800_B4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet"},{"issue":"25","key":"2019050909192672800_B5","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMcp1709318","article-title":"Subclinical hyperthyroidism","volume":"378","author":"Biondi","year":"2018","journal-title":"N Engl J Med"},{"key":"2019050909192672800_B6"},{"issue":"10","key":"2019050909192672800_B7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"2019050909192672800_B8","volume-title":"National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011","author":"Centers for Disease Control and Prevention","year":"2011"},{"issue":"4","key":"2019050909192672800_B9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3928\/0090-4481-19800401-07","article-title":"Autoimmune polyglandular syndromes","volume":"9","author":"Neufeld","year":"1980","journal-title":"Pediatr Ann"},{"issue":"20","key":"2019050909192672800_B10","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"N Engl J Med"},{"issue":"2","key":"2019050909192672800_B11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/dme.12318","article-title":"Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis","volume":"31","author":"Shun","year":"2014","journal-title":"Diabet Med"},{"issue":"5","key":"2019050909192672800_B12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2265.2011.03976.x","article-title":"High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults","volume":"74","author":"Jin","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2019050909192672800_B13","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1365-2265.2000.00983.x","article-title":"Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies","volume":"52","author":"Gambelunghe","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4 Pt 1","key":"2019050909192672800_B14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1399-5448.2008.00400.x","article-title":"Thyroid autoimmunity in children with features of both type 1 and type 2 diabetes","volume":"9","author":"Libman","year":"2008","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"2019050909192672800_B15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1297\/cpe.26.73","article-title":"Hypothyroidism among pediatric patients with type 1 diabetes mellitus, from patients\u2019 characteristics to disease severity","volume":"26","author":"Fatourechi","year":"2017","journal-title":"Clin Pediatr Endocrinol"},{"issue":"2","key":"2019050909192672800_B16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1210\/jc.2015-3235","article-title":"Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway","volume":"101","author":"Fleiner","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B17","first-page":"1181","volume":"26","year":"2003"},{"issue":"8","key":"2019050909192672800_B18","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.2337\/diacare.25.8.1346","article-title":"Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey","volume":"25","author":"Kordonouri","year":"2002","journal-title":"Diabetes Care"},{"issue":"1","key":"2019050909192672800_B19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-09-0044","article-title":"Polyglandular autoimmune syndromes","volume":"161","author":"Kahaly","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2019050909192672800_B20","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1210\/jc.2002-021845","article-title":"Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up","volume":"88","author":"Dittmar","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40618-017-0740-9","article-title":"Polyglandular autoimmune syndromes","volume":"41","author":"Kahaly","year":"2018","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"2019050909192672800_B22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/thy.2010.1639","article-title":"Genetics of the autoimmune polyglandular syndrome type 3 variant","volume":"20","author":"Dittmar","year":"2010","journal-title":"Thyroid"},{"issue":"2","key":"2019050909192672800_B23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/thy.2008.1565","article-title":"Type 1 diabetes and autoimmune thyroiditis: the genetic connection","volume":"19","author":"Tomer","year":"2009","journal-title":"Thyroid"},{"issue":"7","key":"2019050909192672800_B24","first-page":"2559","article-title":"Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity","volume":"81","author":"Huang","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0168-8227(94)01025-U","article-title":"Immunogenetic heterogeneity in type 1 (insulin-dependent) diabetes among Japanese\u2014class II antigen and autoimmune thyroid disease","volume":"27","author":"Chikuba","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"2019050909192672800_B26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1046\/j.1365-2265.1996.00857.x","article-title":"HLA DRB1\/DQA1\/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus","volume":"45","author":"Chuang","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2019050909192672800_B27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/0891693031000101279","article-title":"Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease","volume":"36","author":"Kim","year":"2003","journal-title":"Autoimmunity"},{"issue":"6","key":"2019050909192672800_B28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.humimm.2004.02.026","article-title":"Analysis of HLA genes in families with autoimmune diabetes and thyroiditis","volume":"65","author":"Levin","year":"2004","journal-title":"Hum Immunol"},{"issue":"8","key":"2019050909192672800_B29","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1210\/jc.2004-2236","article-title":"Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes","volume":"90","author":"Golden","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019050909192672800_B30","first-page":"253","article-title":"Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population","volume":"64","author":"Hashimoto","year":"2005","journal-title":"Horm Res"},{"issue":"4","key":"2019050909192672800_B31","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1399-0039.2011.01634.x","article-title":"Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type 1 diabetes","volume":"77","author":"Weinstock","year":"2011","journal-title":"Tissue Antigens"},{"issue":"1","key":"2019050909192672800_B32","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1210\/jc.2013-2852","article-title":"HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III","volume":"99","author":"Flesch","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B33","first-page":"232","article-title":"HLA class II differentiates between thyroid and polyglandular autoimmunity","volume":"48","author":"Barkia Beradhi","year":"2016","journal-title":"Horm Metab Res"},{"issue":"7","key":"2019050909192672800_B34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF03347743","article-title":"The genes influencing the susceptibility to IDDM in humans","volume":"17","author":"Faas","year":"1994","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2019050909192672800_B35","first-page":"113","article-title":"Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type","volume":"52","author":"Holl","year":"1999","journal-title":"Horm Res"},{"issue":"1","key":"2019050909192672800_B36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/EJE-08-0082","article-title":"Early onset of polyglandular failure is associated with HLA-DRB1*03","volume":"159","author":"Dittmar","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"37","key":"2019050909192672800_B37","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1073\/pnas.0806584105","article-title":"Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice","volume":"105","author":"Menconi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019050909192672800_B38","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","article-title":"Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms","volume":"29","author":"Huber","year":"2008","journal-title":"Endocr Rev"},{"issue":"11","key":"2019050909192672800_B39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tibs.2007.08.007","article-title":"Recognition of self-peptide\u2013MHC complexes by autoimmune T-cell receptors","volume":"32","author":"Deng","year":"2007","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"2019050909192672800_B40","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/jc.2008-2193","article-title":"Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families","volume":"94","author":"Villano","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019050909192672800_B41","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V93.6.2013.406k25_2013_2024","article-title":"Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp","volume":"93","author":"Cohen","year":"1999","journal-title":"Blood"},{"issue":"1","key":"2019050909192672800_B42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1084\/jem.189.1.111","article-title":"Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase","volume":"189","author":"Cloutier","year":"1999","journal-title":"J Exp Med"},{"issue":"6","key":"2019050909192672800_B43","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/08916930701464897","article-title":"Protein tyrosine phosphatase PTPN22 in human autoimmunity","volume":"40","author":"Vang","year":"2007","journal-title":"Autoimmunity"},{"issue":"2","key":"2019050909192672800_B44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jc.2006-2064","article-title":"Association of PTPN22 haplotypes with Graves\u2019 disease","volume":"92","author":"Heward","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2\u20133","key":"2019050909192672800_B45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","article-title":"The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future","volume":"28","author":"Jacobson","year":"2007","journal-title":"J Autoimmun"},{"issue":"4","key":"2019050909192672800_B46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","article-title":"Role of PTPN22 in type 1 diabetes and other autoimmune diseases","volume":"18","author":"Bottini","year":"2006","journal-title":"Semin Immunol"},{"issue":"6","key":"2019050909192672800_B47","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/eje.1.02035","article-title":"Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto\u2019s thyroiditis or Addison\u2019s disease in the German population","volume":"153","author":"Kahles","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2019050909192672800_B48","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1210\/jc.2004-1108","article-title":"The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves\u2019 disease","volume":"89","author":"Velaga","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat Genet"},{"issue":"11","key":"2019050909192672800_B50","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.2337\/diabetes.53.11.3020","article-title":"Replication of an association between the lymphoid tyrosine phosphatase locus (LYP\/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus","volume":"53","author":"Smyth","year":"2004","journal-title":"Diabetes"},{"issue":"6","key":"2019050909192672800_B51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/ajmg.a.31124","article-title":"Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations [published correction appears in Am J Med Genet A. 2007;143(15):18212\u201318213]","volume":"140","author":"Kawasaki","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"3","key":"2019050909192672800_B52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/thy.2005.15.239","article-title":"Immunoregulatory and susceptibility genes in thyroid and polyglandular autoimmunity","volume":"15","author":"Dittmar","year":"2005","journal-title":"Thyroid"},{"issue":"2","key":"2019050909192672800_B53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/thy.2008.0301","article-title":"The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes","volume":"19","author":"Dultz","year":"2009","journal-title":"Thyroid"},{"key":"2019050909192672800_B54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaut.2015.03.006","article-title":"Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes","volume":"60","author":"Tomer","year":"2015","journal-title":"J Autoimmun"},{"issue":"1","key":"2019050909192672800_B55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","article-title":"A molecular perspective of CTLA-4 function","volume":"24","author":"Teft","year":"2006","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"2019050909192672800_B56","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.4049\/jimmunol.162.10.5813","article-title":"CTLA-4-mediated inhibition of early events of T cell proliferation","volume":"162","author":"Brunner","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"2019050909192672800_B57","first-page":"143","article-title":"CTLA4 alanine-17 confers genetic susceptibility to Graves\u2019 disease and to type 1 diabetes mellitus","volume":"82","author":"Donner","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6939","key":"2019050909192672800_B58","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","article-title":"Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease","volume":"423","author":"Ueda","year":"2003","journal-title":"Nature"},{"issue":"8","key":"2019050909192672800_B59","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1210\/jc.2007-0147","article-title":"Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis","volume":"92","author":"Kavvoura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/08916930108994124","article-title":"No association of type 1 diabetes with a microsatellite marker for CTLA-4 in a Japanese population","volume":"34","author":"Ban","year":"2001","journal-title":"Autoimmunity"},{"issue":"3","key":"2019050909192672800_B61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1365-2370.2002.00292.x","article-title":"The CTLA4 +49 A\/G dimorphism is not associated with type 1 diabetes in Czech children","volume":"29","author":"Cinek","year":"2002","journal-title":"Eur J Immunogenet"},{"issue":"12","key":"2019050909192672800_B62","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1089\/10507250360731479","article-title":"CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves\u2019 disease","volume":"13","author":"Takara","year":"2003","journal-title":"Thyroid"},{"issue":"1\u20132","key":"2019050909192672800_B63","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0165-5728(02)00228-X","article-title":"Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence","volume":"130","author":"Wang","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"48","key":"2019050909192672800_B64","doi-asserted-by":"crossref","first-page":"46478","DOI":"10.1074\/jbc.M206894200","article-title":"A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele","volume":"277","author":"Anjos","year":"2002","journal-title":"J Biol Chem"},{"issue":"3","key":"2019050909192672800_B65","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcp.21001","article-title":"The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: multiple pathways on the road","volume":"211","author":"Zhang","year":"2007","journal-title":"J Cell Physiol"},{"issue":"5","key":"2019050909192672800_B66","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.20041179","article-title":"Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period","volume":"201","author":"Bayer","year":"2005","journal-title":"J Exp Med"},{"issue":"4","key":"2019050909192672800_B67","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2265.2007.02762.x","article-title":"Association of the interleukin-2 receptor alpha (IL-2R\u03b1)\/CD25 gene region with Graves\u2019 disease using a multilocus test and tag SNPs","volume":"66","author":"Brand","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2019050909192672800_B68","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ni1417","article-title":"Myeloid C-type lectins in innate immunity","volume":"7","author":"Robinson","year":"2006","journal-title":"Nat Immunol"},{"issue":"7","key":"2019050909192672800_B69","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor \u03b1 promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019050909192672800_B70","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2249.1998.00662.x","article-title":"Tumour necrosis factor (TNF) gene polymorphism influences TNF-\u03b1 production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans","volume":"113","author":"Louis","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"3\u20134","key":"2019050909192672800_B71","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08820130902766092","article-title":"The proinflammatory cytokine TNF-\u03b1 -308 AA genotype is associated with polyglandular autoimmunity","volume":"38","author":"Dittmar","year":"2009","journal-title":"Immunol Invest"},{"issue":"2","key":"2019050909192672800_B72","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrendo.2016.151","article-title":"Mitochondrial disease and endocrine dysfunction","volume":"13","author":"Chow","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"13","key":"2019050909192672800_B73","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMra002168","article-title":"Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young","volume":"345","author":"Fajans","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"2019050909192672800_B74","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1210\/me.2004-0215","article-title":"Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1\u03b2 in human papillary thyroid cancer cells","volume":"19","author":"Xu","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"5","key":"2019050909192672800_B75","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/thy.2007.0312","article-title":"Expression of hepatocyte nuclear factor-1\u03b1 mRNA in human anaplastic thyroid cancer cell lines and tumors","volume":"18","author":"Xu","year":"2008","journal-title":"Thyroid"},{"key":"2019050909192672800_B76","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142018.","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"issue":"2","key":"2019050909192672800_B77","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"2019050909192672800_B78","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2019050909192672800_B79","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2337\/dc07-0959","article-title":"Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran","volume":"31","author":"Esteghamati","year":"2008","journal-title":"Diabetes Care"},{"issue":"1","key":"2019050909192672800_B80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00592-006-0204-8","article-title":"Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics","volume":"43","author":"Akbar","year":"2006","journal-title":"Acta Diabetol"},{"issue":"5","key":"2019050909192672800_B81","first-page":"560","article-title":"Antagonist: diabetes and insulin resistance\u2014philosophy, science, and the multiplier hypothesis","volume":"125","author":"Robertson","year":"1995","journal-title":"J Lab Clin Med"},{"issue":"4","key":"2019050909192672800_B82","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2337\/db12-0073","article-title":"Insulin resistance and type 2 diabetes","volume":"61","author":"Taylor","year":"2012","journal-title":"Diabetes"},{"issue":"7","key":"2019050909192672800_B83","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/er.2008-0024","article-title":"The metabolic syndrome","volume":"29","author":"Cornier","year":"2008","journal-title":"Endocr Rev"},{"issue":"1","key":"2019050909192672800_B84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"issue":"4","key":"2019050909192672800_B85","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/diacare.26.4.1251","article-title":"Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck Study","volume":"26","author":"Bonora","year":"2003","journal-title":"Diabetes Care"},{"issue":"4","key":"2019050909192672800_B86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0031-1271691","article-title":"Prevalence of thyroid dysfunction in patients with type 2 diabetes","volume":"119","author":"D\u00edez","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"2","key":"2019050909192672800_B87","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/08916930701777629","article-title":"Association between parity and autoimmune thyroiditis in a general female population","volume":"41","author":"Friedrich","year":"2008","journal-title":"Autoimmunity"},{"issue":"2","key":"2019050909192672800_B88","first-page":"75","article-title":"Prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic","volume":"2","author":"Papazafiropoulou","year":"2010","journal-title":"J Clin Med Res"},{"issue":"6","key":"2019050909192672800_B89","doi-asserted-by":"crossref","first-page":"e66711","DOI":"10.1371\/journal.pone.0066711","article-title":"Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study","volume":"8","author":"Brandt","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2019050909192672800_B90","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/dc14-2515","article-title":"Hypothyroidism is a risk factor for new-onset diabetes mellitus: a cohort study","volume":"38","author":"Gronich","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"2019050909192672800_B91","doi-asserted-by":"crossref","first-page":"e75789","DOI":"10.1371\/journal.pone.0075789","article-title":"Type and extent of somatic morbidity before and after the diagnosis of hypothyroidism. A nationwide register study","volume":"8","author":"Thvilum","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"2019050909192672800_B92","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","article-title":"Frequency of thyroid dysfunction in diabetic patients: value of annual screening","volume":"12","author":"Perros","year":"1995","journal-title":"Diabet Med"},{"issue":"1","key":"2019050909192672800_B93","first-page":"15","article-title":"Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus","volume":"27","author":"Celani","year":"1994","journal-title":"Diabetes Res"},{"key":"2019050909192672800_B94","doi-asserted-by":"crossref","first-page":"390534","DOI":"10.1155\/2013\/390534","article-title":"The relationship between type 2 diabetes mellitus and related thyroid diseases","volume":"2013","author":"Wang","year":"2013","journal-title":"J Diabetes Res"},{"issue":"1","key":"2019050909192672800_B95","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-012-9621-3","article-title":"Subclinical hyperthyroidism in patients with type 2 diabetes","volume":"42","author":"D\u00edez","year":"2012","journal-title":"Endocrine"},{"issue":"3","key":"2019050909192672800_B96","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.diabres.2008.08.017","article-title":"Type 2 diabetes does not predict incident thyroid dysfunction in the elderly","volume":"82","author":"Gopinath","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2019050909192672800_B97","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2265.2005.02246.x","article-title":"Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study","volume":"62","author":"Chubb","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019050909192672800_B98","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4093\/dmj.2015.39.1.66","article-title":"Pattern of thyroid dysfunction in patients with metabolic syndrome and its relationship with components of metabolic syndrome","volume":"39","author":"Gyawali","year":"2015","journal-title":"Diabetes Metab J"},{"key":"2019050909192672800_B99","doi-asserted-by":"crossref","first-page":"417920","DOI":"10.1155\/2013\/417920","article-title":"Risk factors for thyroid dysfunction among type 2 diabetic patients in a highly diabetes mellitus prevalent society","volume":"2013","author":"Al-Geffari","year":"2013","journal-title":"Int J Endocrinol"},{"issue":"1","key":"2019050909192672800_B100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12020-016-1095-2","article-title":"The prevalence and determinants of hypothyroidism in hospitalized patients with type 2 diabetes mellitus","volume":"55","author":"Song","year":"2017","journal-title":"Endocrine"},{"issue":"12","key":"2019050909192672800_B101","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1464-5491.2012.03687.x","article-title":"An analysis of the relative risk for hypothyroidism in patients with type 2 diabetes","volume":"29","author":"D\u00edez","year":"2012","journal-title":"Diabet Med"},{"issue":"5","key":"2019050909192672800_B102","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1530\/EJE-10-0710","article-title":"Associations between cardiovascular risk, insulin resistance, \u03b2-cell function and thyroid dysfunction: a cross-sectional study in She ethnic minority group of Fujian Province in China","volume":"163","author":"Chen","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019050909192672800_B103","author":"Han"},{"issue":"4","key":"2019050909192672800_B104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2265.1983.tb00018.x","article-title":"Natural history of thyroid function in diabetics with impaired thyroid reserve: a four year controlled study","volume":"19","author":"Gray","year":"1983","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2019050909192672800_B105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.maturitas.2009.01.007","article-title":"Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women","volume":"62","author":"Park","year":"2009","journal-title":"Maturitas"},{"issue":"2","key":"2019050909192672800_B106","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jc.2006-1718","article-title":"Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects","volume":"92","author":"Roos","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019050909192672800_B107","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1089\/thy.2014.0103","article-title":"Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects","volume":"24","author":"Mehran","year":"2014","journal-title":"Thyroid"},{"issue":"4","key":"2019050909192672800_B108","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-14-0067","article-title":"Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease","volume":"171","author":"Santini","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019050909192672800_B109","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/thy.2011.0499","article-title":"The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin","volume":"23","author":"Duntas","year":"2013","journal-title":"Thyroid"},{"issue":"1","key":"2019050909192672800_B110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1677\/joe.0.1760007","article-title":"TSH stimulates leptin secretion by a direct effect on adipocytes","volume":"176","author":"Menendez","year":"2003","journal-title":"J Endocrinol"},{"issue":"2","key":"2019050909192672800_B111","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.2040-1124.2012.00203.x","article-title":"The role of leptin in glucose homeostasis","volume":"3","author":"Denroche","year":"2012","journal-title":"J Diabetes Investig"},{"issue":"4","key":"2019050909192672800_B112","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/hep.23800","article-title":"A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate\/protein kinase A\/cyclic adenosine monophosphate-responsive element binding protein pathway","volume":"52","author":"Tian","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"2019050909192672800_B113","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1507\/endocrj.EJ12-0462","article-title":"Decreased fasting blood glucose is associated with impaired hepatic glucose production in thyroid-stimulating hormone receptor knockout mice","volume":"60","author":"Wang","year":"2013","journal-title":"Endocr J"},{"issue":"1","key":"2019050909192672800_B114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1758-5996-6-99","article-title":"Association of adipokines, leptin\/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus","volume":"6","author":"Al-Hamodi","year":"2014","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"2019050909192672800_B115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/joe.0.1740121","article-title":"The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies","volume":"174","author":"Ortiga-Carvalho","year":"2002","journal-title":"J Endocrinol"},{"issue":"3","key":"2019050909192672800_B116","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s12020-016-1221-1","article-title":"TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects","volume":"55","author":"Jun","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"2019050909192672800_B117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.2016.0171","article-title":"Association between changes in thyroid hormones and incident type 2 diabetes: a seven-year longitudinal study","volume":"27","author":"Jun","year":"2017","journal-title":"Thyroid"},{"issue":"3","key":"2019050909192672800_B118","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1476-5381.2010.01056.x","article-title":"Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes","volume":"162","author":"Lin","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"1","key":"2019050909192672800_B119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1096\/fj.11-186841","article-title":"Mitochondrial T3 receptor p43 regulates insulin secretion and glucose homeostasis","volume":"26","author":"Blanchet","year":"2012","journal-title":"FASEB J"},{"issue":"6","key":"2019050909192672800_B120","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0306-9877(02)00211-6","article-title":"A hypothesis of synergism: the interrelationship of T3 and insulin to disturbances in metabolic homeostasis","volume":"59","author":"Kim","year":"2002","journal-title":"Med Hypotheses"},{"issue":"4","key":"2019050909192672800_B121","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2265.2004.02123.x","article-title":"Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients","volume":"61","author":"Yavuz","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019050909192672800_B122","author":"Chaker"},{"issue":"2","key":"2019050909192672800_B123","first-page":"434","article-title":"The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects","volume":"102","author":"Gu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019050909192672800_B124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.beem.2007.04.001","article-title":"Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination","volume":"21","author":"K\u00f6hrle","year":"2007","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2019050909192672800_B125","author":"Gereben"},{"issue":"5","key":"2019050909192672800_B126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0030-1248261","article-title":"Subclinical hypothyroidism affects mitochondrial function","volume":"42","author":"Kvetny","year":"2010","journal-title":"Horm Metab Res"},{"issue":"1","key":"2019050909192672800_B127","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.abb.2007.02.004","article-title":"Role of mitochondria in exercise-induced oxidative stress in skeletal muscle from hyperthyroid rats","volume":"463","author":"Venditti","year":"2007","journal-title":"Arch Biochem Biophys"},{"issue":"9716","key":"2019050909192672800_B128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"2019050909192672800_B129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2019050909192672800_B130","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J Clin Invest"},{"issue":"32","key":"2019050909192672800_B131","doi-asserted-by":"crossref","first-page":"24477","DOI":"10.1074\/jbc.M109.100222","article-title":"Liganded thyroid hormone receptor-\u03b1 enhances proliferation of pancreatic \u03b2-cells","volume":"285","author":"Furuya","year":"2010","journal-title":"J Biol Chem"},{"issue":"9","key":"2019050909192672800_B132","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0024-3205(02)01791-5","article-title":"Evidence for a deficient pancreatic \u03b2-cell response in a rat model of hyperthyroidism","volume":"71","author":"Fukuchi","year":"2002","journal-title":"Life Sci"},{"issue":"5","key":"2019050909192672800_B133","doi-asserted-by":"crossref","first-page":"e19839","DOI":"10.1371\/journal.pone.0019839","article-title":"Thyroid hormone T3 counteracts STZ induced diabetes in mouse","volume":"6","author":"Verga Falzacappa","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"2019050909192672800_B134","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4158\/EP.15.3.254","article-title":"Excess thyroid hormone and carbohydrate metabolism","volume":"15","author":"Potenza","year":"2009","journal-title":"Endocr Pract"},{"issue":"1","key":"2019050909192672800_B135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2011.04029.x","article-title":"The interface between thyroid and diabetes mellitus","volume":"75","author":"Duntas","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019050909192672800_B136","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1210\/endo-102-1-182","article-title":"Effect of thyrotoxicosis on gluconeogenesis from alanine in the perfused rat liver","volume":"102","author":"Singh","year":"1978","journal-title":"Endocrinology"},{"issue":"Pt 3","key":"2019050909192672800_B137","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/bj3090913","article-title":"Regulation of phosphoenolpyruvate carboxykinase gene transcription by thyroid hormone involves two distinct binding sites in the promoter","volume":"309","author":"Park","year":"1995","journal-title":"Biochem J"},{"issue":"1","key":"2019050909192672800_B138","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1074\/jbc.274.1.211","article-title":"Role of CCAAT enhancer-binding protein \u03b2 in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription","volume":"274","author":"Park","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"2019050909192672800_B139","doi-asserted-by":"crossref","first-page":"E513","DOI":"10.1152\/ajpendo.00659.2007","article-title":"Effects of thyrotoxicosis and selective hepatic autonomic denervation on hepatic glucose metabolism in rats","volume":"294","author":"Klieverik","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019050909192672800_B140","doi-asserted-by":"crossref","first-page":"152850","DOI":"10.4061\/2011\/152850","article-title":"Why can insulin resistance be a natural consequence of thyroid dysfunction","volume":"2011","author":"Brenta","year":"2011","journal-title":"J Thyroid Res"},{"issue":"14","key":"2019050909192672800_B141","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1073\/pnas.0805355106","article-title":"Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventricular nucleus to the liver","volume":"106","author":"Klieverik","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2019050909192672800_B142","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/mend.14.7.0470","article-title":"Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray","volume":"14","author":"Feng","year":"2000","journal-title":"Mol Endocrinol"},{"issue":"6","key":"2019050909192672800_B143","first-page":"383","article-title":"Thyroid hormone. Basis for its hypocholesterolemic effect","volume":"78","author":"Ness","year":"1991","journal-title":"J Fla Med Assoc"},{"issue":"9","key":"2019050909192672800_B144","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbalip.2007.05.001","article-title":"Activation of the hepatic LDL receptor promoter by thyroid hormone","volume":"1771","author":"Lopez","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"36","key":"2019050909192672800_B145","doi-asserted-by":"crossref","first-page":"34114","DOI":"10.1074\/jbc.M305417200","article-title":"Thyroid hormone regulation and cholesterol metabolism are connected through sterol regulatory element-binding protein-2 (SREBP-2)","volume":"278","author":"Shin","year":"2003","journal-title":"J Biol Chem"},{"issue":"10","key":"2019050909192672800_B146","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2014.07.001","article-title":"Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism","volume":"25","author":"Sinha","year":"2014","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"2019050909192672800_B147","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1172\/JCI60580","article-title":"Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy","volume":"122","author":"Sinha","year":"2012","journal-title":"J Clin Invest"},{"issue":"2","key":"2019050909192672800_B148","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/thy.2007.0249","article-title":"Links between thyroid hormone action, oxidative metabolism, and diabetes risk","volume":"18","author":"Crunkhorn","year":"2008","journal-title":"Thyroid"},{"key":"2019050909192672800_B149","author":"Weinstein"},{"issue":"50","key":"2019050909192672800_B150","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.271.50.32048","article-title":"Characterization of the promoter of the rat sarcoplasmic endoplasmic reticulum Ca2+-ATPase 1 gene and analysis of thyroid hormone responsiveness","volume":"271","author":"Simonides","year":"1996","journal-title":"J Biol Chem"},{"issue":"17","key":"2019050909192672800_B151","doi-asserted-by":"crossref","first-page":"13021","DOI":"10.1016\/S0021-9258(18)99978-3","article-title":"Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5\u2032 to thyroid hormone receptor in response element 1","volume":"269","author":"Hartong","year":"1994","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"2019050909192672800_B152","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/BJ20041073","article-title":"Thyroid hormones directly activate the expression of the human and mouse uncoupling protein-3 genes through a thyroid response element in the proximal promoter region","volume":"386","author":"Solanes","year":"2005","journal-title":"Biochem J"},{"issue":"1","key":"2019050909192672800_B153","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-201X.2004.01380.x","article-title":"Mechanisms regulating GLUT4 glucose transporter expression and glucose transport in skeletal muscle","volume":"183","author":"Zorzano","year":"2005","journal-title":"Acta Physiol Scand"},{"issue":"2","key":"2019050909192672800_B154","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0021-9258(17)35275-4","article-title":"Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element","volume":"266","author":"Desvergne","year":"1991","journal-title":"J Biol Chem"},{"issue":"Pt 3","key":"2019050909192672800_B155","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1042\/bj3170913","article-title":"Regulation of adenine nucleotide translocase and glycerol 3-phosphate dehydrogenase expression by thyroid hormones in different rat tissues","volume":"317","author":"D\u00fcmmler","year":"1996","journal-title":"Biochem J"},{"issue":"7","key":"2019050909192672800_B156","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/thy.2011.0422","article-title":"Triiodothyronine acutely stimulates glucose transport into L6 muscle cells without increasing surface GLUT4, GLUT1, or GLUT3","volume":"22","author":"Teixeira","year":"2012","journal-title":"Thyroid"},{"issue":"6","key":"2019050909192672800_B157","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/MCO.0b013e32833e341d","article-title":"Adipocyte-myocyte crosstalk in skeletal muscle insulin resistance; is there a role for thyroid hormone","volume":"13","author":"Havekes","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2019050909192672800_B158","author":"de Lange"},{"issue":"2","key":"2019050909192672800_B159","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1152\/physrev.00030.2013","article-title":"Thyroid hormone regulation of metabolism","volume":"94","author":"Mullur","year":"2014","journal-title":"Physiol Rev"},{"issue":"2","key":"2019050909192672800_B160","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/thy.2007.0266","article-title":"Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate","volume":"18","author":"Kim","year":"2008","journal-title":"Thyroid"},{"key":"2019050909192672800_B161","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1055\/s-2001-18584","article-title":"Thyroid hormone excess and glucose intolerance","volume":"109","author":"Dimitriadis","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"2019050909192672800_B162","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2362.1988.tb01275.x","article-title":"Insulin resistance in Graves\u2019 disease: a quantitative in-vivo evaluation","volume":"18","author":"Cavallo-Perin","year":"1988","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2019050909192672800_B163","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/EJE-10-0246","article-title":"Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism","volume":"163","author":"Maratou","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019050909192672800_B164","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2337\/diab.35.2.178","article-title":"Insulin sensitivity and exogenous insulin clearance in Graves\u2019 disease. Measurement by the glucose clamp technique and continuous indirect calorimetry","volume":"35","author":"Randin","year":"1986","journal-title":"Diabetes"},{"issue":"4","key":"2019050909192672800_B165","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1210\/jcem-70-4-1167","article-title":"Peripheral glucose metabolism in human hyperthyroidism","volume":"70","author":"Foss","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B166","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s005920200040","article-title":"Association between diabetic ketoacidosis and thyrotoxicosis","volume":"39","author":"Sol\u00e1","year":"2002","journal-title":"Acta Diabetol"},{"key":"2019050909192672800_B167","author":"Donckier"},{"issue":"2","key":"2019050909192672800_B168","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/bj1820565","article-title":"Metabolism of glucose in hyper- and hypo-thyroid rats in vivo. Glucose-turnover values and futile-cycle activities obtained with 14C- and 3H-labelled glucose","volume":"182","author":"Okajima","year":"1979","journal-title":"Biochem J"},{"issue":"3","key":"2019050909192672800_B169","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1210\/edrv-5-3-411","article-title":"Thyroid hormones, gonadal and adrenocortical steroids and the function of the islets of Langerhans","volume":"5","author":"Lenzen","year":"1984","journal-title":"Endocr Rev"},{"issue":"3","key":"2019050909192672800_B170","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1172\/JCI109889","article-title":"Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle","volume":"66","author":"Czech","year":"1980","journal-title":"J Clin Invest"},{"issue":"6","key":"2019050909192672800_B171","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2362.1997.1380688.x","article-title":"The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats","volume":"27","author":"Dimitriadis","year":"1997","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"2019050909192672800_B172","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00125-005-1696-4","article-title":"Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusion","volume":"48","author":"Cettour-Rose","year":"2005","journal-title":"Diabetologia"},{"issue":"5","key":"2019050909192672800_B173","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-08-0797","article-title":"Studies of insulin resistance in patients with clinical and subclinical hypothyroidism","volume":"160","author":"Maratou","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019050909192672800_B174","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/thy.2009.0108","article-title":"Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance","volume":"19","author":"Brenta","year":"2009","journal-title":"Thyroid"},{"issue":"12","key":"2019050909192672800_B175","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1210\/jc.2006-0478","article-title":"Insulin action in adipose tissue and muscle in hypothyroidism","volume":"91","author":"Dimitriadis","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019050909192672800_B176","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2265.2011.04328.x","article-title":"Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study","volume":"76","author":"Waring","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2019050909192672800_B177","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1515\/CCLM.2005.121","article-title":"Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy","volume":"43","author":"Stanick\u00e1","year":"2005","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"2019050909192672800_B178","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1210\/jc.2005-0298","article-title":"Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study","volume":"90","author":"Chubb","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019050909192672800_B179","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1365-2265.2008.03280.x","article-title":"Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)","volume":"69","author":"Handisurya","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019050909192672800_B180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1464-5491.2002.00635.x","article-title":"The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus","volume":"19","author":"Mohn","year":"2002","journal-title":"Diabet Med"},{"issue":"5","key":"2019050909192672800_B181","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2337\/diacare.6.5.512","article-title":"Diabetes mellitus and thyroid disease","volume":"6","author":"Mouradian","year":"1983","journal-title":"Diabetes Care"},{"issue":"3","key":"2019050909192672800_B182","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2337\/diaspect.19.3.148","article-title":"Diabetes control in thyroid disease","volume":"19","author":"Johnson","year":"2006","journal-title":"Diabetes Spectr"},{"issue":"2","key":"2019050909192672800_B183","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2337\/diab.41.2.147","article-title":"Effects of streptozocin-induced diabetes and food restriction on quantities and source of T4 and T3 in rat tissues","volume":"41","author":"Schr\u00f6der-van der Elst","year":"1992","journal-title":"Diabetes"},{"key":"2019050909192672800_B184","first-page":"627","volume-title":"Frontiers in Endocrinology","author":"Moura","year":"1986"},{"issue":"15\u201316","key":"2019050909192672800_B185","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/0024-3205(81)90348-9","article-title":"Alterations in hepatic monodeiodination of iodothyronines in the diabetic rat","volume":"28","author":"Chopra","year":"1981","journal-title":"Life Sci"},{"issue":"1","key":"2019050909192672800_B186","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/acta.0.1060086","article-title":"Decreased T4 to T3 conversion in tissues of streptozotocin-diabetic rats","volume":"106","author":"Ortiz-Caro","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"2019050909192672800_B187","first-page":"913","article-title":"A comparative study of thyroid hormone levels in diabetic and non-diabetic patients","volume":"39","author":"Islam","year":"2008","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"2019050909192672800_B188","first-page":"5","volume":"2","year":"2000","journal-title":"J Gorgan Uni Med Sci"},{"issue":"4","key":"2019050909192672800_B189","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0030-1269880","article-title":"Effect of hyperthyroidism on clearance and secretion of glucagon in man","volume":"119","author":"Dimitriadis","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2019050909192672800_B190"},{"issue":"6","key":"2019050909192672800_B191","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2265.1978.tb02183.x","article-title":"A low T3 syndrome in diabetic ketoacidosis","volume":"8","author":"Naeije","year":"1978","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019050909192672800_B192","first-page":"465","article-title":"The mechanism of thyroid hormone abnormalities in patients with diabetes mellitus [in Japanese]","volume":"70","author":"Suzuki","year":"1994","journal-title":"Nippon Naibunpi Gakkai Zasshi"},{"issue":"1","key":"2019050909192672800_B193","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/jc.2005-1210","article-title":"Thyrotropin suppression by metformin","volume":"91","author":"Vigersky","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019050909192672800_B194","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000438750","article-title":"The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism","volume":"4","author":"Biondi","year":"2015","journal-title":"Eur Thyroid J"},{"issue":"10","key":"2019050909192672800_B195","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"2019050909192672800_B196","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1210\/er.2006-0043","article-title":"The clinical significance of subclinical thyroid dysfunction","volume":"29","author":"Biondi","year":"2008","journal-title":"Endocr Rev"},{"issue":"12","key":"2019050909192672800_B197","first-page":"4701","article-title":"Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients","volume":"85","author":"Biondi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B198","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of subclinical hypothyroidism","volume":"2","author":"Pearce","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"12","key":"2019050909192672800_B199","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"2019050909192672800_B200","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dcS13-2038","article-title":"Intolerance to statins: mechanisms and management","volume":"36","author":"Bitzur","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"2019050909192672800_B201","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"2019050909192672800_B202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-007-9012-3","article-title":"Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy","volume":"32","author":"Isidro","year":"2007","journal-title":"Endocrine"},{"issue":"9","key":"2019050909192672800_B203","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/dc09-0273","article-title":"TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients","volume":"32","author":"Cappelli","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"2019050909192672800_B204","doi-asserted-by":"crossref","first-page":"E143","DOI":"10.1210\/jc.2013-2965","article-title":"Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies","volume":"99","author":"Lupoli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2265.2012.04468.x","article-title":"Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes","volume":"78","author":"D\u00edez","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019050909192672800_B206","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/met.2010.0026","article-title":"Metformin treatment for small benign thyroid nodules in patients with insulin resistance","volume":"9","author":"Rezz\u00f3nico","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"2019050909192672800_B207","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-12-0225","article-title":"Thyreotropin levels in diabetic patients on metformin treatment","volume":"167","author":"Cappelli","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019050909192672800_B208","first-page":"280","article-title":"Does metformin have a \u201cbuffer effect\u201d on serum TSH levels in euthyroid diabetic patients","volume":"14","author":"Santos-Palacios","year":"2015","journal-title":"Hormones (Athens)"},{"issue":"1","key":"2019050909192672800_B209","first-page":"22","article-title":"Metformin and thyroid: an update","volume":"2","author":"Pappa","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"10","key":"2019050909192672800_B210","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1089\/thy.2015.0211","article-title":"Metformin does not suppress serum thyrotropin by increasing levothyroxine absorption","volume":"25","author":"Al-Alusi","year":"2015","journal-title":"Thyroid"},{"issue":"5","key":"2019050909192672800_B211","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"\u0141abuzek","year":"2010","journal-title":"Pharmacol Rep"},{"issue":"3","key":"2019050909192672800_B212","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2011.04058.x","article-title":"Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone","volume":"75","author":"Krysiak","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2019050909192672800_B213","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.molmed.2013.04.004","article-title":"Energy balance regulation by thyroid hormones at central level","volume":"19","author":"L\u00f3pez","year":"2013","journal-title":"Trends Mol Med"},{"issue":"9","key":"2019050909192672800_B214","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm.2207","article-title":"Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance","volume":"16","author":"L\u00f3pez","year":"2010","journal-title":"Nat Med"},{"issue":"2","key":"2019050909192672800_B215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/en.2006-1237","article-title":"Metformin inhibits adenosine 5\u2032-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons","volume":"148","author":"Chau-Van","year":"2007","journal-title":"Endocrinology"},{"issue":"1","key":"2019050909192672800_B216","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.1.05844","article-title":"Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome","volume":"184","author":"Ortega-Gonz\u00e1lez","year":"2005","journal-title":"J Endocrinol"},{"key":"2019050909192672800_B217","doi-asserted-by":"crossref","first-page":"215718","DOI":"10.4061\/2011\/215718","article-title":"Thyroid hormone and the neuroglia: both source and target","volume":"2011","author":"Moh\u00e1csik","year":"2011","journal-title":"J Thyroid Res"},{"issue":"3","key":"2019050909192672800_B218","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/EJE-10-0419","article-title":"Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis","volume":"163","author":"Dora","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019050909192672800_B219","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"issue":"12","key":"2019050909192672800_B220","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1089\/thy.2013.0114","article-title":"Are levothyroxine requirements lower in thyroidectomized diabetic patients on metformin treatment","volume":"23","author":"Caster\u00e0s","year":"2013","journal-title":"Thyroid"},{"issue":"4","key":"2019050909192672800_B221","doi-asserted-by":"crossref","first-page":"E510","DOI":"10.1210\/jc.2011-1754","article-title":"Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents","volume":"97","author":"Chen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019050909192672800_B222","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/ERC-12-0046","article-title":"Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells","volume":"19","author":"Klubo-Gwiezdzinska","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2019050909192672800_B223","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/endo-63-4-473","article-title":"Mechanism of antithyroid effects of a sulfonylurea in the rat","volume":"63","author":"Brown","year":"1958","journal-title":"Endocrinology"},{"issue":"IV","key":"2019050909192672800_B224","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/acta.0.XXXIII0623","article-title":"Thyroid function in diabetic patients under long-term sulfonylurea treatment","volume":"33","author":"Nikkila","year":"1960","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"1","key":"2019050909192672800_B225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/096032718300200112","article-title":"Antithyroid effect of chlorpropamide","volume":"2","author":"Feely","year":"1983","journal-title":"Hum Toxicol"},{"issue":"4","key":"2019050909192672800_B226","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02582089","article-title":"Effect of iodine administration on thyroid function in diabetic patients","volume":"21","author":"Robuschi","year":"1984","journal-title":"Acta Diabetol Lat"},{"issue":"3","key":"2019050909192672800_B227","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/endo-67-3-293","article-title":"The effect of oral hypoglycemic agents on thyroid function in the rat","volume":"67","author":"Tranquada","year":"1960","journal-title":"Endocrinology"},{"issue":"11","key":"2019050909192672800_B228","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/jcem-28-11-1605","article-title":"Effect of sulfonylurea drugs on the binding of triiodothyronine and thyroxine to thyroxine-binding globulin","volume":"28","author":"Hershman","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"2019050909192672800_B229","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/0168-8227(91)90012-3","article-title":"Evaluation of the efficacy and safety of Diamicron in non-insulin-dependent diabetic patients","volume":"14","author":"Kilo","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"2019050909192672800_B230","first-page":"471","article-title":"Glyburide does not alter thyroid function","volume":"3","author":"England","year":"1986","journal-title":"Diabetes Res"},{"issue":"8","key":"2019050909192672800_B231","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1055\/s-2007-1012364","article-title":"Effect of glibenclamide on thyroid hormone metabolism in rats","volume":"18","author":"Ikeda","year":"1986","journal-title":"Horm Metab Res"},{"issue":"14","key":"2019050909192672800_B232","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM197704072961405","article-title":"Clinical pharmacology of oral antidiabetic agents (second of two parts)","volume":"296","author":"Shen","year":"1977","journal-title":"N Engl J Med"},{"key":"2019050909192672800_B233","first-page":"173","article-title":"Effects of second generation sulfonylureas on the thyroid","volume":"4","author":"Efe","year":"1999","journal-title":"Turk J Endocrinol Metab."},{"issue":"11","key":"2019050909192672800_B234","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"2019050909192672800_B235","first-page":"2352","article-title":"Stimulation of adipogenesis, peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3), and thyrotropin receptor by PPAR\u03b3 agonist in human orbital preadipocyte fibroblasts","volume":"87","author":"Valyasevi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B236","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1677\/jme.0.0330133","article-title":"Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves\u2019 ophthalmopathy","volume":"33","author":"Pasquali","year":"2004","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"2019050909192672800_B237","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2005.03.039","article-title":"PPAR\u03b3-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells","volume":"183","author":"Pistrosch","year":"2005","journal-title":"Atherosclerosis"},{"issue":"9","key":"2019050909192672800_B238","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/105072503322401032","article-title":"Peroxisome proliferator-activated receptor-\u03b3 gene expression in orbital adipose\/connective tissues is increased during the active stage of Graves\u2019 ophthalmopathy","volume":"13","author":"Mimura","year":"2003","journal-title":"Thyroid"},{"issue":"1","key":"2019050909192672800_B239","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2006.02542.x","article-title":"Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes","volume":"65","author":"Dorkhan","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"2019050909192672800_B240","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/07853890.2013.851865","article-title":"Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes","volume":"45","author":"Tseng","year":"2013","journal-title":"Ann Med"},{"issue":"3","key":"2019050909192672800_B241","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"2019050909192672800_B242","author":"Tseng"},{"issue":"6","key":"2019050909192672800_B243","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4158\/EP13143.OR","article-title":"Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone","volume":"19","author":"Essig","year":"2013","journal-title":"Endocr Pract"},{"issue":"4","key":"2019050909192672800_B244","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation [published correction appears in Endocrinology. 2012;153(2):1000]","volume":"151","author":"Bjerre Knudsen","year":"2010","journal-title":"Endocrinology"},{"issue":"3","key":"2019050909192672800_B245","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s004410051371","article-title":"Correlation between gender and spontaneous C-cell tumors in the thyroid gland of the Wistar rat","volume":"297","author":"Mart\u00edn-Lacave","year":"1999","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2019050909192672800_B246","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/019262338901700205","article-title":"The effects of xenobiotics on the structure and function of thyroid follicular and C-cells","volume":"17","author":"Capen","year":"1989","journal-title":"Toxicol Pathol"},{"issue":"7","key":"2019050909192672800_B247","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-0599","article-title":"The safety of incretin-based therapies\u2014review of the scientific evidence","volume":"96","author":"Drucker","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019050909192672800_B248","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2010-2318","article-title":"GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide","volume":"96","author":"Heged\u00fcs","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019050909192672800_B249","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/dc17-1956","article-title":"No evidence of increase in calcitonin concentrations or development of C-Cell malignancy in response to liraglutide for up to 5 years in the LEADER Trial","volume":"41","author":"Heged\u00fcs","year":"2018","journal-title":"Diabetes Care"},{"issue":"11","key":"2019050909192672800_B250","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrendo.2015.155","article-title":"Scope and limitations of iodothyronine deiodinases in hypothyroidism","volume":"11","author":"Gereben","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"8","key":"2019050909192672800_B251","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/thy.2005.15.777","article-title":"Cellular and structural biology of the deiodinases","volume":"15","author":"Bianco","year":"2005","journal-title":"Thyroid"},{"issue":"9","key":"2019050909192672800_B252","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1172\/JCI25083","article-title":"Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans","volume":"115","author":"Maia","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"2019050909192672800_B253","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/thy.2005.15.899","article-title":"Peripheral metabolism of thyroid hormone and glucose homeostasis","volume":"15","author":"Chidakel","year":"2005","journal-title":"Thyroid"},{"issue":"3","key":"2019050909192672800_B254","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2337\/diabetes.51.3.880","article-title":"Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the \u03b2-3-adrenergic receptor","volume":"51","author":"Mentuccia","year":"2002","journal-title":"Diabetes"},{"key":"2019050909192672800_B255","unstructured":"National Center for Biotechnology Information. 1000 Genomes browser. Available at: https:\/\/www.ncbi.nlm.nih.gov\/variation\/tools\/1000genomes\/. Accessed 30 April 2019."},{"issue":"1","key":"2019050909192672800_B256","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/thy.2010.0455","article-title":"Association analyses of variants in the DIO2 gene with early-onset type 2 diabetes mellitus in Pima Indians","volume":"22","author":"Nair","year":"2012","journal-title":"Thyroid"},{"issue":"6","key":"2019050909192672800_B257","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1210\/jc.2004-1977","article-title":"The type 2 deiodinase A\/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus","volume":"90","author":"Canani","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B258","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2006-1958","article-title":"Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects","volume":"92","author":"Grarup","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019050909192672800_B259","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/thy.2006.0298","article-title":"The type 2 deiodinase (DIO2) A\/G polymorphism is not associated with glycemic traits: the Framingham Heart Study","volume":"17","author":"Maia","year":"2007","journal-title":"Thyroid"},{"issue":"11","key":"2019050909192672800_B260","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/thy.2005.15.1223","article-title":"The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish","volume":"15","author":"Mentuccia","year":"2005","journal-title":"Thyroid"},{"issue":"4","key":"2019050909192672800_B261","first-page":"E733","article-title":"Exercise and insulin cause GLUT-4 translocation in human skeletal muscle","volume":"277","author":"Thorell","year":"1999","journal-title":"Am J Physiol"},{"key":"2019050909192672800_B262","doi-asserted-by":"crossref","first-page":"5928726","DOI":"10.1155\/2016\/5928726","article-title":"The type 2 deiodinase Thr92Ala polymorphism is associated with worse glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"2016","author":"Zhang","year":"2016","journal-title":"J Diabetes Res"},{"issue":"17","key":"2019050909192672800_B263","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"9468","key":"2019050909192672800_B264","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"issue":"15","key":"2019050909192672800_B265","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"issue":"15","key":"2019050909192672800_B266","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"van Marken Lichtenbelt","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"2019050909192672800_B267","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI200112584","article-title":"Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific","volume":"108","author":"Ribeiro","year":"2001","journal-title":"J Clin Invest"},{"issue":"34","key":"2019050909192672800_B268","doi-asserted-by":"crossref","first-page":"18168","DOI":"10.1016\/S0021-9258(19)81340-6","article-title":"Triiodothyronine amplifies norepinephrine stimulation of uncoupling protein gene transcription by a mechanism not requiring protein synthesis","volume":"263","author":"Bianco","year":"1988","journal-title":"J Biol Chem"},{"issue":"5","key":"2019050909192672800_B269","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/thy.2007.0018","article-title":"Appetite regulation: an overview","volume":"17","author":"Dhillo","year":"2007","journal-title":"Thyroid"},{"issue":"25","key":"2019050909192672800_B270","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.95.25.15043","article-title":"The neuropeptide Y\/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice","volume":"95","author":"Broberger","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019050909192672800_B271","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0896-6273(00)80656-X","article-title":"Leptin activates hypothalamic CART neurons projecting to the spinal cord","volume":"21","author":"Elias","year":"1998","journal-title":"Neuron"},{"issue":"4","key":"2019050909192672800_B272","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1210\/endo.133.4.8404618","article-title":"Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity","volume":"133","author":"Zarjevski","year":"1993","journal-title":"Endocrinology"},{"issue":"8","key":"2019050909192672800_B273","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/endo.142.8.8304","article-title":"Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei","volume":"142","author":"Abbott","year":"2001","journal-title":"Endocrinology"},{"issue":"2","key":"2019050909192672800_B274","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-4886(95)90045-4","article-title":"Characteristics of BDNF-induced weight loss","volume":"131","author":"Pelleymounter","year":"1995","journal-title":"Exp Neurol"},{"issue":"7","key":"2019050909192672800_B275","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nn1073","article-title":"Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor","volume":"6","author":"Xu","year":"2003","journal-title":"Nat Neurosci"},{"issue":"1","key":"2019050909192672800_B276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-9384(02)00784-9","article-title":"TRH decreases food intake and increases water intake and body temperature in rats","volume":"77","author":"Choi","year":"2002","journal-title":"Physiol Behav"},{"issue":"3","key":"2019050909192672800_B277","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000123544","article-title":"Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat","volume":"37","author":"Lin","year":"1983","journal-title":"Neuroendocrinology"},{"issue":"2","key":"2019050909192672800_B278","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/thy.2007.0253","article-title":"Fasting-induced changes in the hypothalamus-pituitary-thyroid axis","volume":"18","author":"Boelen","year":"2008","journal-title":"Thyroid"},{"issue":"11","key":"2019050909192672800_B279","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1210\/en.2004-0545","article-title":"Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure","volume":"145","author":"Kong","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"2019050909192672800_B280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmet.2006.12.002","article-title":"A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2","volume":"5","author":"Coppola","year":"2007","journal-title":"Cell Metab"},{"issue":"2","key":"2019050909192672800_B281","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.3984","article-title":"Hypothalamic mTOR pathway mediates thyroid hormone-induced hyperphagia in hyperthyroidism","volume":"227","author":"Varela","year":"2012","journal-title":"J Pathol"},{"issue":"8","key":"2019050909192672800_B282","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1210\/en.2005-1229","article-title":"Expression of vesicular glutamate transporter-2 in gonadotrope and thyrotrope cells of the rat pituitary. Regulation by estrogen and thyroid hormone status","volume":"147","author":"Hrabovszky","year":"2006","journal-title":"Endocrinology"},{"issue":"2","key":"2019050909192672800_B283","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/thy.2007.0251","article-title":"The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor","volume":"18","author":"Hollenberg","year":"2008","journal-title":"Thyroid"},{"issue":"12","key":"2019050909192672800_B284","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1210\/me.2010-0203","article-title":"Regulation of thyrotropin-releasing hormone-expressing neurons in paraventricular nucleus of the hypothalamus by signals of adiposity","volume":"24","author":"Ghamari-Langroudi","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"6836","key":"2019050909192672800_B285","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/35078085","article-title":"Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus","volume":"411","author":"Cowley","year":"2001","journal-title":"Nature"},{"issue":"11","key":"2019050909192672800_B286","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/diab.45.11.1638","article-title":"Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity","volume":"45","author":"Houseknecht","year":"1996","journal-title":"Diabetes"},{"issue":"2","key":"2019050909192672800_B287","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1507\/endocrj.52.213","article-title":"TSH influences serum leptin levels independent of thyroid hormones in hypothyroid and hyperthyroid patients","volume":"52","author":"Oge","year":"2005","journal-title":"Endocr J"},{"issue":"1-3","key":"2019050909192672800_B288","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-0115(00)00145-2","article-title":"Regulation of in vivo TSH secretion by leptin","volume":"92","author":"Seoane","year":"2000","journal-title":"Regul Pept"},{"issue":"5738","key":"2019050909192672800_B289","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/282503a0","article-title":"Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons","volume":"282","author":"Woods","year":"1979","journal-title":"Nature"},{"issue":"6","key":"2019050909192672800_B290","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nn0602-861","article-title":"Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats","volume":"5","author":"Obici","year":"2002","journal-title":"Nat Neurosci"},{"issue":"3","key":"2019050909192672800_B291","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0149-7634(86)90015-1","article-title":"The role of glucose, insulin and glucagon in the regulation of food intake and body weight","volume":"10","author":"Grossman","year":"1986","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"2019050909192672800_B292","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.physbeh.2005.04.005","article-title":"Impaired glucose signaling as a cause of obesity and the metabolic syndrome: the glucoadipostatic hypothesis","volume":"85","author":"Mobbs","year":"2005","journal-title":"Physiol Behav"},{"issue":"11","key":"2019050909192672800_B293","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1089\/thy.2014.0169","article-title":"A thyroid hormone challenge in hypothyroid rats identifies T3 regulated genes in the hypothalamus and in models with altered energy balance and glucose homeostasis","volume":"24","author":"Herwig","year":"2014","journal-title":"Thyroid"},{"issue":"24","key":"2019050909192672800_B294","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"issue":"5708","key":"2019050909192672800_B295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1104342","article-title":"How obesity causes diabetes: not a tall tale","volume":"307","author":"Lazar","year":"2005","journal-title":"Science"},{"issue":"8","key":"2019050909192672800_B296","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1210\/jc.2010-1245","article-title":"Thyroid and obesity: an intriguing relationship","volume":"95","author":"Biondi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019050909192672800_B297","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0002-9343(84)90842-8","article-title":"Long-term weight regulation in treated hyperthyroid and hypothyroid subjects","volume":"76","author":"Hoogwerf","year":"1984","journal-title":"Am J Med"},{"issue":"4","key":"2019050909192672800_B298","first-page":"1118","article-title":"Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement","volume":"82","author":"al-Adsani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2019050909192672800_B299","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1210\/jc.2004-2225","article-title":"Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population","volume":"90","author":"Knudsen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B300","doi-asserted-by":"crossref","first-page":"e34979","DOI":"10.1371\/journal.pone.0034979","article-title":"Body fatness and markers of thyroid function among U.S. men and women","volume":"7","author":"Kitahara","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"2019050909192672800_B301","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archinte.168.6.587","article-title":"Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample","volume":"168","author":"Fox","year":"2008","journal-title":"Arch Intern Med"},{"key":"2019050909192672800_B302","author":"Feldt-Rasmussen"},{"issue":"4","key":"2019050909192672800_B303","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.0.1490257","article-title":"Circulating leptin and thyroid dysfunction","volume":"149","author":"Zimmermann-Belsing","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019050909192672800_B304","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-10-0138","article-title":"Acute exogenous TSH administration stimulates leptin secretion in vivo","volume":"163","author":"Santini","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019050909192672800_B305","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/thy.2006.16.73","article-title":"Thyroid function in humans with morbid obesity","volume":"16","author":"Michalaki","year":"2006","journal-title":"Thyroid"},{"issue":"8","key":"2019050909192672800_B306","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2009-2798","article-title":"Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid autoimmunity independent of bioanthropometric, hormonal, and weight-related determinants","volume":"95","author":"Marzullo","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B307","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2265.2008.03304.x","article-title":"Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects","volume":"70","author":"Kim","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019050909192672800_B308","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000351249","article-title":"Thyroid hormones and the metabolic syndrome","volume":"2","author":"Iwen","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"2","key":"2019050909192672800_B309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/EJE-07-0592","article-title":"Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals","volume":"158","author":"Ortega","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019050909192672800_B310","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-12-0447","article-title":"Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men","volume":"167","author":"Roef","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019050909192672800_B311","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-10-0312","article-title":"TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects","volume":"163","author":"Gardu\u00f1o-Garcia","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019050909192672800_B312","doi-asserted-by":"crossref","first-page":"104318","DOI":"10.1155\/2014\/104318","article-title":"Association between lower normal free thyroxine concentrations and obesity phenotype in healthy euthyroid subjects","volume":"2014","author":"Shin","year":"2014","journal-title":"Int J Endocrinol"},{"issue":"2","key":"2019050909192672800_B313","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/thy.2013.0314","article-title":"Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects","volume":"24","author":"Roef","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"2019050909192672800_B314","first-page":"1206","article-title":"The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects","volume":"86","author":"Bakker","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B315","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2007.0223","article-title":"Introducing the thyroid gland as another victim of the insulin resistance syndrome","volume":"18","author":"Rezzonico","year":"2008","journal-title":"Thyroid"},{"issue":"2","key":"2019050909192672800_B316","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/jc.2011-2532","article-title":"Update in lipid alterations in subclinical hypothyroidism","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019050909192672800_B317","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2265.2005.02399.x","article-title":"Thyroid dysfunction and serum lipids: a community-based study","volume":"63","author":"Walsh","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019050909192672800_B318","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"issue":"11","key":"2019050909192672800_B319","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1089\/thy.2007.0116","article-title":"Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence","volume":"17","author":"Duntas","year":"2007","journal-title":"Thyroid"},{"issue":"3","key":"2019050909192672800_B320","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2009.03640.x","article-title":"Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study","volume":"72","author":"Boekholdt","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2019050909192672800_B321","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-11-0261","article-title":"Association between serum TSH concentration within the normal range and adiposity","volume":"165","author":"de Moura Souza","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2019050909192672800_B322","first-page":"432","article-title":"Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome","volume":"26","author":"Lee","year":"2011","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"issue":"2","key":"2019050909192672800_B323","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/eje.1.02333","article-title":"The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study","volume":"156","author":"Asvold","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019050909192672800_B324","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4158\/EP13237.OR","article-title":"Association between subclinical hypothyroidism and blood pressure\u2014a meta-analysis of observational studies","volume":"20","author":"Ye","year":"2014","journal-title":"Endocr Pract"},{"issue":"10","key":"2019050909192672800_B325","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/hr.2011.91","article-title":"Blood pressure levels in patients with subclinical thyroid dysfunction: a meta-analysis of cross-sectional data","volume":"34","author":"Cai","year":"2011","journal-title":"Hypertens Res"},{"issue":"2","key":"2019050909192672800_B326","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/thy.2007.0248","article-title":"Metabolic effects of thyroid hormone derivatives","volume":"18","author":"Moreno","year":"2008","journal-title":"Thyroid"},{"issue":"1","key":"2019050909192672800_B327","first-page":"14","article-title":"Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults","volume":"20","author":"Kim","year":"2011","journal-title":"Asia Pac J Clin Nutr"},{"issue":"4","key":"2019050909192672800_B328","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2337\/dc11-1849","article-title":"Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD)","volume":"35","author":"Ortiz-Lopez","year":"2012","journal-title":"Diabetes Care"},{"key":"2019050909192672800_B329","doi-asserted-by":"crossref","first-page":"5753039","DOI":"10.1155\/2017\/5753039","article-title":"Benefits of levothyroxine replacement therapy on nonalcoholic fatty liver disease in subclinical hypothyroidism patients","volume":"2017","author":"Liu","year":"2017","journal-title":"Int J Endocrinol"},{"key":"2019050909192672800_B330","author":"Erdogan"},{"key":"2019050909192672800_B331"},{"issue":"2","key":"2019050909192672800_B332","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/07435800.2015.1108332","article-title":"Subclinical hypothyroidism and the risk of metabolic syndrome: a meta-analysis of observational studies","volume":"41","author":"Yang","year":"2016","journal-title":"Endocr Res"},{"issue":"3","key":"2019050909192672800_B333","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/met.2015.0065","article-title":"The association between subclinical hypothyroidism and metabolic syndrome as defined by the ATP III criteria","volume":"14","author":"Eftekharzadeh","year":"2016","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"2019050909192672800_B334","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-12-0375","article-title":"Thyroid function and the metabolic syndrome in older persons: a population-based study","volume":"168","author":"Heima","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2019050909192672800_B335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jc.2006-1718","article-title":"Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects","volume":"92","author":"Roos","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019050909192672800_B336","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2265.2009.03698.x","article-title":"A high normal TSH is associated with the metabolic syndrome","volume":"72","author":"Ruhla","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019050909192672800_B337","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3346\/jkms.2011.26.4.540","article-title":"The relation of thyroid function to components of the metabolic syndrome in Korean men and women","volume":"26","author":"Park","year":"2011","journal-title":"J Korean Med Sci"},{"issue":"10","key":"2019050909192672800_B338","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"2019050909192672800_B339","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jacc.2005.12.046","article-title":"Metabolic syndrome and the risk of cardiovascular disease in older adults","volume":"47","author":"Butler","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2019050909192672800_B340","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1871530317666170320105221","article-title":"Thyroid hormones, metabolic syndrome and its components","volume":"17","author":"Delitala","year":"2017","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"1","key":"2019050909192672800_B341","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1507\/endocrj.K10E-272","article-title":"The relationship between serum thyrotropin and components of metabolic syndrome","volume":"58","author":"Lai","year":"2011","journal-title":"Endocr J"},{"issue":"16","key":"2019050909192672800_B342","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2019050909192672800_B343","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.26.3.855","article-title":"Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study","volume":"26","author":"Vaur","year":"2003","journal-title":"Diabetes Care"},{"issue":"10","key":"2019050909192672800_B344","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2019050909192672800_B345","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diacare.25.1.43","article-title":"Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study","volume":"25","author":"Roper","year":"2002","journal-title":"Diabetes Care"},{"key":"2019050909192672800_B346"},{"issue":"21","key":"2019050909192672800_B347","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"issue":"18","key":"2019050909192672800_B348","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"2019050909192672800_B349","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"2019050909192672800_B350","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"issue":"9","key":"2019050909192672800_B351","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"2019050909192672800_B352","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1464-5491.2007.02270.x","article-title":"Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients","volume":"24","author":"Chen","year":"2007","journal-title":"Diabet Med"},{"issue":"5","key":"2019050909192672800_B353","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/dc09-1784","article-title":"An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients","volume":"33","author":"Yang","year":"2010","journal-title":"Diabetes Care"},{"issue":"12","key":"2019050909192672800_B354","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1507\/endocrj.EJ11-0199","article-title":"Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes","volume":"58","author":"Kim","year":"2011","journal-title":"Endocr J"},{"issue":"2","key":"2019050909192672800_B355","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"key":"2019050909192672800_B356","author":"Wu"},{"issue":"3","key":"2019050909192672800_B357","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.diabres.2011.08.019","article-title":"Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes","volume":"94","author":"Yasuda","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2019050909192672800_B358","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.2337\/dc09-1555","article-title":"Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes","volume":"33","author":"Sathyapalan","year":"2010","journal-title":"Diabetes Care"},{"issue":"4","key":"2019050909192672800_B359","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2265.2006.02481.x","article-title":"Subclinical hypothyroidism and mortality in women with type 2 diabetes","volume":"64","author":"Chubb","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2019050909192672800_B360","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"issue":"12","key":"2019050909192672800_B361","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.2337\/diacare.28.12.2901","article-title":"Type 2 diabetes as a \u201ccoronary heart disease equivalent\u201d: an 18-year prospective population-based study in Finnish subjects","volume":"28","author":"Juutilainen","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"2019050909192672800_B362","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"issue":"8","key":"2019050909192672800_B363","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/dme.12724","article-title":"Subclinical hypothyroidism and the associations with macrovascular complications and chronic kidney disease in patients with Type 2 diabetes","volume":"32","author":"Jia","year":"2015","journal-title":"Diabet Med"},{"key":"2019050909192672800_B364","author":"Lazarus"},{"issue":"3","key":"2019050909192672800_B365","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"issue":"3","key":"2019050909192672800_B366","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1210\/er.2013-1083","article-title":"Treatment with thyroid hormone","volume":"35","author":"Biondi","year":"2014","journal-title":"Endocr Rev"},{"issue":"9677","key":"2019050909192672800_B367","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"2019050909192672800_B368","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.2337\/diacare.25.10.1862","article-title":"Gestational diabetes and the incidence of type 2 diabetes: a systematic review","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"2019050909192672800_B369","volume-title":"Laboratory Diagnosis and Monitoring of Diabetes Mellitus","author":"World Health Organization","year":"2002"},{"issue":"5","key":"2019050909192672800_B370","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpm-2012-0015","article-title":"The prevalence of gestational diabetes in advanced economies","volume":"40","author":"Schneider","year":"2012","journal-title":"J Perinat Med"},{"issue":"9","key":"2019050909192672800_B371","first-page":"489","article-title":"Management of gestational diabetes [in French]","volume":"68","author":"Philips","year":"2013","journal-title":"Rev Med Liege"},{"issue":"4","key":"2019050909192672800_B372","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clp.2007.09.003","article-title":"Diabetic-associated stillbirth: incidence, pathophysiology, and prevention","volume":"34","author":"Dudley","year":"2007","journal-title":"Clin Perinatol"},{"issue":"12","key":"2019050909192672800_B373","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1210\/jc.2008-0772","article-title":"Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions","volume":"93","author":"Ratner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019050909192672800_B374","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/eje.0.1470443","article-title":"Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1","volume":"147","author":"Gallas","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2019050909192672800_B375","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4158\/EP13440.RA","article-title":"Maternal subclinical hypothyroidsm and gestational diabetes mellitus: a meta-analysis","volume":"20","author":"Toulis","year":"2014","journal-title":"Endocr Pract"},{"issue":"12","key":"2019050909192672800_B376","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2011-1784","article-title":"Lower free thyroxin associates with a less favorable metabolic phenotype in healthy pregnant women","volume":"96","author":"Bassols","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B377","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/EJE-15-0866","article-title":"Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters","volume":"174","author":"Knight","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2019050909192672800_B378","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e318250aeeb","article-title":"Relationship of subclinical thyroid disease to the incidence of gestational diabetes","volume":"119","author":"Tudela","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2019050909192672800_B379","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.fertnstert.2015.06.003","article-title":"Thyroid antibodies and gestational diabetes mellitus: a meta-analysis","volume":"104","author":"Yang","year":"2015","journal-title":"Fertil Steril"},{"issue":"12","key":"2019050909192672800_B380","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1210\/jc.2012-2540","article-title":"Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes","volume":"97","author":"Karakosta","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019050909192672800_B381","author":"Zhang"},{"issue":"11","key":"2019050909192672800_B382","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2016-1506","article-title":"Low thyroid hormone in early pregnancy is associated with an increased risk of gestational diabetes mellitus","volume":"101","author":"Yang","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2019050909192672800_B383","author":"Riise"},{"issue":"7","key":"2019050909192672800_B384","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.cjca.2013.12.030","article-title":"Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals: an overview and grading of the evidence","volume":"30","author":"Nerenberg","year":"2014","journal-title":"Can J Cardiol"},{"issue":"3","key":"2019050909192672800_B385","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1210\/jc.2009-1904","article-title":"Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life","volume":"95","author":"M\u00e4nnist\u00f6","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019050909192672800_B386","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1530\/eje.0.1460275","article-title":"Post-partum thyroiditis\u2014a clinical update","volume":"146","author":"Roti","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2019050909192672800_B387","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/thy.1999.9.685","article-title":"Clinical manifestations of postpartum thyroid disease","volume":"9","author":"Lazarus","year":"1999","journal-title":"Thyroid"},{"key":"2019050909192672800_B388","author":"Gerstein"},{"issue":"1","key":"2019050909192672800_B389","first-page":"10","article-title":"Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus","volume":"79","author":"Alvarez-Marfany","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2019050909192672800_B390","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline","volume":"97","author":"De Groot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019050909192672800_B391","unstructured":"British Thyroid Association and Association of Clinical Biochemistry Guidelines . 2016. www.british-thyroid-association.org\/current-bta-guidelines. Accessed 30 April 2019."},{"key":"2019050909192672800_B392"},{"key":"2019050909192672800_B393","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc09-S013","article-title":"Standards of medical care in diabetes\u20132009","volume":"32","author":"American Diabetes Association","year":"2009","journal-title":"Diabetes Care"},{"key":"2019050909192672800_B394","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2337\/dc16-S014","article-title":"11. Children and adolescents","volume":"39","author":"American Diabetes Association","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"2019050909192672800_B395","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin","year":"2002","journal-title":"Endocr Pract"},{"issue":"3","key":"2019050909192672800_B396","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1399-5448.2007.00249.x","article-title":"ISPAD clinical practice consensus guidelines 2006\u20132007. Other complications and associated conditions","volume":"8","author":"Kordonouri","year":"2007","journal-title":"Pediatr Diabetes"},{"key":"2019050909192672800_B397","author":"Rugge"},{"issue":"11","key":"2019050909192672800_B398","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.160.11.1573","article-title":"American Thyroid Association guidelines for detection of thyroid dysfunction","volume":"160","author":"Ladenson","year":"2000","journal-title":"Arch Intern Med"},{"issue":"5","key":"2019050909192672800_B399","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1210\/jc.2017-02577","article-title":"PTPN22 and CTLA-4 polymorphisms are associated with polyglandular autoimmunity","volume":"103","author":"Houcken","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019050909192672800_B400","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"issue":"12","key":"2019050909192672800_B401","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/er.2018-00163\/27498690\/er.2018-00163.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/40\/3\/789\/28574671\/er.2018-00163.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T22:11:42Z","timestamp":1720908702000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/40\/3\/789\/5288751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":401,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,1,14]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2018-00163","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,1,14]]}}}